Pritesh Shah

Companies

• NovoCure LtdChief Commercial Officer Jul 10, 2018 to Nov 8, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NNovoCure Ltd NVCR124,511 shares²$1.8M at $14.41Nov 7, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 7, 2023Sold 382 shares at $12.65 of NovoCure Ltd²
• Sep 1, 2023Sold 273 shares at $21.82 of NovoCure Ltd³
• Jun 30, 2023Granted 367 shares at $35.28 of NovoCure Ltd⁴
• Mar 3, 2023Sold 16,909 shares at $76.16 of NovoCure Ltd⁵
• Mar 3, 2023Granted 43,246 shares of NovoCure Ltd⁶
• Mar 3, 2023Sold 2,942 shares at $76.16 of NovoCure Ltd⁵
• Mar 3, 2023Granted 3,936 shares of NovoCure Ltd⁶
• Mar 3, 2023Sold 1,570 shares at $76.16 of NovoCure Ltd⁵
• Mar 2, 2023Sold 937 shares at $75.28 of NovoCure Ltd⁶
• Mar 1, 2023Sold 1,923 shares at $76.36 of NovoCure Ltd⁷
• Feb 28, 2023Granted 19,055 shares of NovoCure Ltd⁷
• Jan 5, 2023Sold 387 shares at $108.00 of NovoCure Ltd⁸
• Sep 2, 2022Sold 269 shares at $79.04 of NovoCure Ltd⁹
• Jul 5, 2022Granted 312 shares at $59.08 of NovoCure Ltd¹⁰
• Mar 9, 2022Sold 3,669 shares at $71.19 of NovoCure Ltd¹¹
• Mar 8, 2022Sold 2,481 shares at $70.10 of NovoCure Ltd¹²
• Mar 7, 2022Sold 5,294 shares at $69.55 of NovoCure Ltd¹²
• Mar 4, 2022Sold 1,914 shares at $70.41 of NovoCure Ltd¹³
• Mar 4, 2022Sold 2,632 shares at $73.34 of NovoCure Ltd¹³
• Mar 3, 2022Sold 997 shares at $74.50 of NovoCure Ltd¹³
• Mar 3, 2022Granted 21,714 shares of NovoCure Ltd¹³
• Jul 31, 2021Exercised options 3,717 shares at $154.01 of NovoCure Ltd¹¹